News Category: Advocacy

NHIA member pharmacies began reporting that TRICARE patients had received letters from Express Scripts stating the local home infusion pharmacy they currently use will not be in network as of October 24, 2022. NHIA sent a letter to Defense Health Agency and Express Scripts requesting the repeal of any network pharmacy cancellations.
NHIA submitted comments pointing out the advantages of home-based administration of subcutaneous Ig (SCIG) for chronic inflammatory demyelinating polyneuropathy (CIPD).
NHIA submitted comments on a CMS proposed rule (CMS-1770-P) that would affect Medicare payments and coverage of COVID-19 vaccines and monoclonal antibodies (mAbs) and coding and billing requirements related to the use of single dose containers and drug waste.